zofran side effects

  • Date: Nov 27, 2015
  • Category: Legal

Louisiana Mother’s Lawsuit Named In Zofran MDL 2657

Twelve lawsuits have been included in Schedule A of the Zofran MDL order, including one filed by a mother in Louisiana. Continue reading →

  • Date: Nov 20, 2015
  • Category: Legal

California Zofran Lawsuit Alleges GlaxoSmithKline Marketed Drug “Off Label”

GlaxoSmithKline has been accused of knowingly promoting their drug Zofran “off-label” to expectant mothers in one of the latest Zofran lawsuits, filed in California. Continue reading →

  • Date: Nov 13, 2015
  • Category: Legal

“Andersen Study” Cited In Newest Zofran Lawsuit

The latest Zofran lawsuit has indicated that several epidemiological studies, including the “Andersen Study”, have concluded there is an increased risk for birth defects when a mother takes Zofran during her pregnancy. Continue reading →

  • Date: Nov 06, 2015
  • Category: Legal

New Zofran Lawsuit Filed By Arkansas Mother

A mother residing in Arkansas is one of the latest to file a lawsuit against GlaxoSmithKline, alleging that the company’s drug Zofran caused birth defects in her son. Continue reading →

  • Date: Oct 23, 2015
  • Category: Legal

Zofran Lawsuit Plaintiffs Receive Good News About MDL

The Judicial Panel on Multidistrict Litigation announced that all Zofran lawsuits will now be consolidated into MDL 2657. Continue reading →

  • Date: Oct 16, 2015
  • Category: Legal

Zofran Lawsuit Claims Drug Caused Child’s Cardiac Defects

Alabama parents have claimed that the drug Zofran caused their child’s cardiac defects. Continue reading →

  • Date: Oct 09, 2015
  • Category: Legal

New Zofran Lawsuit Alleges Drug Caused Child’s Cleft Lip

The parents of a Missouri child have alleged that the drug Zofran caused their child’s birth defect. Continue reading →

  • Date: Oct 02, 2015
  • Category: Legal

Zofran Lawsuit Claims Boy Required Eight Surgeries Due To Drug

A young boy in Ohio suffers from a cleft lip and cleft palate, which his mother alleges were caused by her ingestion of Zofran during her pregnancy. Continue reading →

  • Date: Sep 25, 2015
  • Category: Legal

New Zofran Birth Defects Lawsuit Filed In Mississippi

A mother in Mississippi has filed a lawsuit against GlaxoSmithKline, claiming her son was born with a cleft palate because of the drug Zofran. Continue reading →

  • Date: Sep 18, 2015
  • Category: Legal

Zofran Lawsuit Alleges Child’s Cardiac Defect – A TGV – Caused By Zofran

A Massachusetts child was born with a severe cardiac defect after her mother was prescribed Zofran while she was pregnant. Continue reading →

  • Date: May 08, 2015
  • Category: Family

A New Zofran Lawsuit Claims Birth Defects Caused Termination

On April 17, 2015, a woman from Massachusetts filed suit against pharmaceutical giant GlaxoSmithKline. She claims that Zofran, an anti-nausea drug frequently prescribed “off-label” to treat morning sickness, caused her unborn child to develop a severe abdominal birth defect. As a result, plaintiff was forced to terminate her pregnancy. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →